Cases 31 - 40 of 332
Sandoz Inc. v. Amgen Inc. et al
as 2:2022cv05326
Petitioner:
Sandoz Inc.
Defendant:
Amgen Inc. and Amgen Manufacturing Limited
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
ARAGON PHARMACEUTICALS, INC. et al v. SANDOZ INC.
as 2:2022cv03044
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
SANDOZ INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Genentech, Inc. v. Sandoz Inc.
as 22-1714
Plaintiff / Appellee:
GENENTECH, INC. and INTERMUNE, INC.
Defendant / Appellant:
SANDOZ INC. and LEK PHARMACEUTICALS, D.D.
Aragon Pharmaceuticals, Inc. et al v. Sandoz Inc.
as 1:2022cv00678
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genentech, Inc. v. Sandoz Inc.
as 22-1595
Plaintiff / Appellant:
GENENTECH, INC. and INTERMUNE, INC.
Defendant / Cross Appellant:
SANDOZ INC.
Defendant / Appellee:
LEK PHARMACEUTICALS, D.D.
Otsuka Pharmaceutical Co., Ltd. et al v. Sandoz Inc. et al
as 1:2022cv00591
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Sandoz Inc. and Sandoz International GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. Sandoz Inc.
as 1:2022cv00164
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PUMA BIOTECHNOLOGY, INC. et al v. SANDOZ INC.
as 1:2021cv19918
Plaintiff:
PUMA BIOTECHNOLOGY, INC. and WYETH LLC
Defendant:
SANDOZ INC.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
